{"title":"Robotic-enhanced hybrid ablation for inappropriate sinus tachycardia: a world-first approach.","authors":"Zain Khalpey, Ujjawal Kumar, Alyssa Abraham, Yoaav Krauthammer","doi":"10.1093/icvts/ivae184","DOIUrl":null,"url":null,"abstract":"<p><p>We describe a world-first robotic ablation for inappropriate sinus tachycardia. A 26-year-old woman with refractory inappropriate sinus tachycardia underwent robotic-enhanced hybrid ablation, combining electrophysiological mapping with superior visualization and access compared to VATS approaches. Ablations normalized the heart rate from 120 to 70bpm. One month later, she reported symptom resolution and improved quality of life. Holter monitoring confirmed no tachycardic episodes. This presents a promising alternative for patients who have exhausted conventional treatments, potentially revolutionizing IST management.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary cardiovascular and thoracic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/icvts/ivae184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
We describe a world-first robotic ablation for inappropriate sinus tachycardia. A 26-year-old woman with refractory inappropriate sinus tachycardia underwent robotic-enhanced hybrid ablation, combining electrophysiological mapping with superior visualization and access compared to VATS approaches. Ablations normalized the heart rate from 120 to 70bpm. One month later, she reported symptom resolution and improved quality of life. Holter monitoring confirmed no tachycardic episodes. This presents a promising alternative for patients who have exhausted conventional treatments, potentially revolutionizing IST management.